Cargando…
RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays
RNA splicing is an essential step in producing mature messenger RNA (mRNA) and other RNA species. Harnessing RNA splicing modifiers as a new pharmacological modality is promising for the treatment of diseases caused by aberrant splicing. This drug modality can be used for infectious diseases by disr...
Autores principales: | Tang, Zhichao, Zhao, Junxing, Pearson, Zach J., Boskovic, Zarko V., Wang, Jingxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070285/ https://www.ncbi.nlm.nih.gov/pubmed/33919699 http://dx.doi.org/10.3390/molecules26082263 |
Ejemplares similares
-
Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences
por: Hegde, Shalakha, et al.
Publicado: (2021) -
Corrigendum: Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences
por: Hegde, Shalakha, et al.
Publicado: (2022) -
Cellular Target Deconvolution of Small Molecules Using
a Selection-Based Genetic Screening Platform
por: Zhao, Junxing, et al.
Publicado: (2022) -
Recognition of single-stranded nucleic acids by small-molecule splicing modulators
por: Tang, Zhichao, et al.
Publicado: (2021) -
Pharmacodynamic assays to facilitate preclinical and clinical development of pre-mRNA splicing modulatory drug candidates
por: Shi, Yihui, et al.
Publicado: (2015)